Browsing: Topics

47-6 OUD.png
Ongoing barriers to medication-assisted treatment for opioid use disorder contribute to a major care gap, with only 10% of patients seeking long-term OUD treatment able to receive it. It's time to imp
47-6 Subarachnoid Hemorrhage CT.jpg
Subarachnoid hemorrhage is a terrifying, relatively frequent cause of intracranial bleeding. It has a significant degree of morbidity and mortality - and therefore is a can't-miss diagnosis.
47-6 New Board Angela Cai.jpg
The EMRA Representative Council chose Angela Cai, MD, MBA, as EMRA President-elect in October. Get to know Dr. Cai.
47-6 New Board RJ Sontag.jpg
RJ Sontag, MD, inherited the gavel of EMRA President in October. Learn more about his goals, experience, and outlook.
47-6 Heart of EM - Answered.jpg
In the midst of the COVID-19 pandemic, with the hospital bursting at the seams and patients growing sicker and sicker as they edged toward a lonely death, I answered.
47-6 lefamulin.jpg
A novel antibiotic that may play a role in ED management of community acquired pneumonia is lefamulin. What is this medication? How could it fit in the ED paradigm for pneumonia treatment?
47-6 New Board Ashley Tarchione.jpg
Do you know who leads the EMRA Representative Council, which sets priorities and directions for the association? Meet your newest Vice Speaker of the Council, Ashley Tarchione.
CCA - ECMO CPR.jpg
What is possible with highly coordinated ECMO-facilitated cardiopulmonary resuscitation? A recent study demonstrates the value of exploring interesting alternatives such as ECMO cannulation in the eme
47-6 Airway.png
The year of 2019 ushered in an abundance of interesting, practice-informing, and excellently conducted research regarding airway and peri-intubation management that is potentially applicable to the em
47-6 Bells Palsy.jpg
Bell's palsy, also called idiopathic facial nerve palsy, is the paralysis of facial motor function without an identifiable cause. It typically presents with sudden onset unilateral facial paralysis an